FDx Advisors’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,041
| Closed | -$236K | – | 352 |
|
|
2023
Q4 | $236K | Sell |
3,041
-1,776
| -37% | -$131K | 0.02% | 605 |
|
|
2023
Q3 | $339K | Sell |
4,817
-2,769
| -37% | -$207K | 0.03% | 438 |
|
|
2023
Q2 | $604K | Sell |
7,586
-177
| -2% | -$12.8K | 0.03% | 402 |
|
|
2023
Q1 | $639K | Hold |
7,763
| – | – | 0.03% | 375 |
|
|
2022
Q4 | $639K | Sell |
7,763
-67
| -0.9% | -$5.52K | 0.03% | 375 |
|
|
2022
Q3 | $612K | Sell |
7,830
-115
| -1% | -$9.19K | 0.03% | 373 |
|
|
2022
Q2 | $537K | Buy |
7,945
+598
| +8% | +$41.7K | 0.02% | 459 |
|
|
2022
Q1 | $481K | Sell |
7,347
-1,504
| -17% | -$87.4K | 0.02% | 521 |
|
|
2021
Q4 | $537K | Buy |
8,851
+1,382
| +19% | +$82.4K | 0.01% | 510 |
|
|
2021
Q3 | $476K | Buy |
7,469
+149
| +2% | +$9.41K | 0.02% | 531 |
|
|
2021
Q2 | $459K | Buy |
7,320
+381
| +5% | +$23.9K | 0.02% | 526 |
|
|
2021
Q1 | $396K | Buy |
6,939
+1,576
| +29% | +$85.3K | 0.01% | 533 |
|
|
2020
Q4 | $270K | Buy |
+5,363
| New | +$214K | 0.01% | 602 |
|
|
2020
Q1 | – | Sell |
-8,848
| Closed | -$294K | – | 509 |
|
|
2019
Q4 | $294K | Sell |
8,848
-10,233
| -54% | -$321K | 0.02% | 490 |
|
|
2019
Q3 | $593K | Buy |
19,081
+2,650
| +16% | +$80.7K | 0.04% | 314 |
|
|
2019
Q2 | $574K | Sell |
16,431
-717
| -4% | -$23.2K | 0.02% | 455 |
|
|
2019
Q1 | $503K | Buy |
17,148
+5,992
| +54% | +$170K | 0.02% | 464 |
|
|
2018
Q4 | $287K | Sell |
11,156
-19,963
| -64% | -$691K | 0.02% | 425 |
|
|
2018
Q3 | $1.09M | Buy |
31,119
+3,646
| +13% | +$145K | 0.04% | 323 |
|
|
2018
Q2 | $1.12M | Buy |
27,473
+4,254
| +18% | +$172K | 0.04% | 343 |
|
|
2018
Q1 | $910K | Buy |
23,219
+3,257
| +16% | +$119K | 0.03% | 539 |
|
|
2017
Q4 | $651K | Buy |
19,962
+3,658
| +22% | +$127K | 0.02% | 691 |
|
|
2017
Q3 | $779K | Buy |
+16,304
| New | +$795K | 0.02% | 615 |
|
|
2016
Q3 | – | Sell |
-7,188
| Closed | -$398K | – | 897 |
|
|
2016
Q2 | $398K | Sell |
7,188
-705
| -9% | -$41.2K | 0.02% | 664 |
|
|
2016
Q1 | $435K | Buy |
7,893
+49
| +0.6% | +$2.8K | 0.02% | 628 |
|
|
2015
Q4 | $490K | Buy |
7,844
+108
| +1% | +$7.04K | 0.02% | 565 |
|
|
2015
Q3 | $513K | Buy |
7,736
+1,123
| +17% | +$86.4K | 0.04% | 434 |
|
|
2015
Q2 | $518K | Buy |
6,613
+913
| +16% | +$65.7K | 0.03% | 563 |
|
|
2015
Q1 | $406K | Sell |
5,700
-759
| -12% | -$48.7K | 0.01% | 1060 |
|
|
2014
Q4 | $395K | Buy |
6,459
+1,087
| +20% | +$63.3K | 0.02% | 629 |
|
|
2014
Q3 | $261K | Buy |
+5,372
| New | +$263K | 0.02% | 835 |
|
Other funds holding ACHC
FDx Advisors's ACHC Position: Q1 2024 in Review
FDx Advisors sold out of Acadia Healthcare (ACHC) in Q1 2024, closing a stake of 3,041 shares — an estimated $236K sold.
FDx Advisors first reported a position in ACHC in Q3 2014 and held it in 31 quarters. The position peaked at $1.12M in Q2 2018. 322 funds tracked by Wall St. Rank hold ACHC as of Q1 2024.
- FDx Advisors reported no remaining Acadia Healthcare position as of Q1 2024 after selling out during the quarter.
- FDx Advisors sold 3,041 Acadia Healthcare shares in Q1 2024, an estimated $236K.
- FDx Advisors first reported a position in Acadia Healthcare in Q3 2014 and held it in 31 quarters.
- FDx Advisors's Acadia Healthcare position peaked at $1.12M in Q2 2018.
- 322 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2024.
Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.